Concepedia

Ioanna Mavrommati

IM

Statistics

Publications

8

Citations

607

H-Index

8

Active since

2013

Affiliations

Queen Mary University of London(Current)

Cancer Research UK

University of Oxford

Curtin University

Institute of Cancer Research

Ioanna Mavrommati is an author at Queen Mary University of London specializing in molecular oncology, life sciences, and oncology.

ORCID

Publications per year

2013–2023

8

Publications

8

Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation

Sophia X. Pfister, Enni Markkanen, Yanyan Jiang et al. · Cancer Cell · 2015 · 309 citations · Full text

, , +12

GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine

Riccardo Ferro, Aleksandra Adamska, Rossano Lattanzio et al. · Oncogene · 2018 · 114 citations · Full text

, , +11

β-TrCP- and Casein Kinase II-Mediated Degradation of Cyclin F Controls Timely Mitotic Progression

Ioanna Mavrommati, Roberta Faedda, Giovanni Galasso et al. · Cell Reports · 2018 · 44 citations · Full text

, , +17

SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response

Philip Bland, Harry Saville, Patty T. Wai et al. · Nature Genetics · 2023 · 43 citations · Full text

, , +17

Novel roles for class II Phosphoinositide 3-Kinase C2β in signalling pathways involved in prostate cancer cell invasion

Ioanna Mavrommati, Ouma Cisse, Marco Falasca et al. · Scientific Reports · 2016 · 26 citations · Full text

, , +17

1–5 of 8